Ryan Rilinger
YOU?
Author Swipe
View article: NCOG-18. Characterization of intra-operative monitoring in CNS WHO Grade 4 glioma
NCOG-18. Characterization of intra-operative monitoring in CNS WHO Grade 4 glioma Open
OBJECTIVES We describe patients undergoing intra-operative monitoring (IOM) with MRI (IMRI) or electrocorticography (ECoG) during primary resection of CNS WHO Grade 4 gliomas and compare clinical outcomes to identify potential benefits of …
View article: Low-Dose Naltrexone for Managing Pain and Autonomic Symptoms in Patients With Dysautonomia
Low-Dose Naltrexone for Managing Pain and Autonomic Symptoms in Patients With Dysautonomia Open
Introduction Low-dose naltrexone (LDN) has been studied in recent years as a novel off-label therapy for several conditions under the umbrella of dysautonomia, which is defined as disorders affecting the autonomic nervous system (ANS), inc…
View article: NCOG-38. LAMOTRIGINE MONOTHERAPY ASSOCIATES WITH IMPROVED PROGRESSION-FREE AND OVERALL SURVIVAL IN HIGH-GRADE GLIOMA
NCOG-38. LAMOTRIGINE MONOTHERAPY ASSOCIATES WITH IMPROVED PROGRESSION-FREE AND OVERALL SURVIVAL IN HIGH-GRADE GLIOMA Open
BACKGROUND High-grade gliomas (HGG) are aggressive brain tumors with notoriously poor prognoses and high symptomatic burden, including seizures in 30-60% of HGG cases. Despite negative impacts to quality of life, positive seizure history a…
View article: SDPS-35 TUMOR-RELATED EPILEPSY IN HIGH-GRADE GLIOMA: A LARGE SERIES SURVIVAL ANALYSIS
SDPS-35 TUMOR-RELATED EPILEPSY IN HIGH-GRADE GLIOMA: A LARGE SERIES SURVIVAL ANALYSIS Open
BACKGROUND Seizures are a common clinical occurrence throughout the disease course in glioblastoma (GBM). While many studies have explored the impact of surgical and medical treatment for GBM on seizure incidence and prevalence, limited st…